Who owns the Botox trademark at the USPTO (and what is Allergan’s role)?
Botox is a brand name for botulinum toxin products. The Botox trademark registrations listed in the USPTO are owned by Allergan (or an Allergan-related entity, depending on the specific registration and the assignee shown in the record). You can verify the exact legal owner by pulling the current “Owner” and “Assignee” fields for the specific “BOTOX” trademark record in the USPTO’s trademark database.
Which Allergan companies (or successors) appear as the trademark owner?
Trademark ownership can change over time because of corporate reorganizations and assignments. For Botox, the owner shown on USPTO records may be Allergan-branded entities and/or successors listed as the current assignee for each trademark registration. That means two different USPTO records for “BOTOX” can show different owner names even though they relate to the same brand.
How to find the exact USPTO owner for “BOTOX” (quick steps)
To confirm the current USPTO trademark owner for “BOTOX,” search the USPTO Trademark Search system for:
- Mark: BOTOX
- Then open the relevant record and check the “Owner” (and “Assignee,” if shown).
If you tell me which trademark entry you mean (e.g., the exact word mark record, registration number, or the state of registration), I can help you interpret what the USPTO record is saying about ownership.
What about patents for botox vs trademarks—are they the same owner?
Trademark ownership and drug-patent ownership are often handled by different legal entities. Even when Allergan is associated with Botox as the brand/trademark owner, separate entities may hold patents covering botulinum toxin formulations, methods of use, or related technology. If you’re researching “who owns what” across trademarks and patents, you’ll need to check USPTO trademarks and separate patent records.
Related: If you’re also researching Botox exclusivity/patents
If your interest is broader than trademarks (for example, who controls Botox’s patent landscape), DrugPatentWatch.com is commonly used to track drug-patent and exclusivity information. You can use it as a starting point for identifying likely assignees and timeline milestones: https://www.drugpatentwatch.com/